LifeMD Q1 2024 Adj EPS $0.01 Beats $(0.15) Estimate, Sales $44.144M Beat $42.540M Estimate
LifeMD Q1 2024 Adj EPS $0.01 Beats $(0.15) Estimate, Sales $44.144M Beat $42.540M Estimate
LifeMD 2024年第一季度調整後每股收益爲0.01美元，超過預期（0.15美元），銷售額爲4,4144萬美元，超過42.54億美元的預期
LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.15) by 106.67 percent. This is a 83.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $44.144 million which beat the analyst consensus estimate of $42.540 million by 3.77 percent. This is a 33.26 percent increase over sales of $33.126 million the same period last year.
LifeMD（納斯達克股票代碼：LFMD）公佈的季度收益爲每股0.01美元，比分析師普遍預期的美元（0.15美元）高出106.67％。與去年同期的每股收益0.06美元相比，下降了83.33％。該公司公佈的季度銷售額爲4,4144萬美元，比分析師普遍預期的4,25.4億美元高出3.77％。這比去年同期的3312.6萬美元的銷售額增長了33.26％。